<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from Circa
Pharmaceuticals, Inc. consolidated financial statements for the quarterly
period ended March 31, 1995 and is qualified in its entirety by reference to
such financial statements.
</LEGEND>
<CIK> 0000013006
<NAME> CIRCA PHARMACEUTICALS, INC.
       
                             
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1995
<PERIOD-END>                               MAR-31-1995
<CASH>                                        23070000
<SECURITIES>                                  32738000
<RECEIVABLES>                                  2485000
<ALLOWANCES>                                    405000
<INVENTORY>                                    1409000
<CURRENT-ASSETS>                              61420000
<PP&E>                                        31311000
<DEPRECIATION>                                18058000
<TOTAL-ASSETS>                               108083000
<CURRENT-LIABILITIES>                          5731000
<BONDS>                                              0
<COMMON>                                        221000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                    91923000
<TOTAL-LIABILITY-AND-EQUITY>                 108083000
<SALES>                                        2717000
<TOTAL-REVENUES>                               7917000
<CGS>                                          1591000
<TOTAL-COSTS>                                  1591000
<OTHER-EXPENSES>                               5055000
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                7161000
<INCOME-TAX>                                     95000
<INCOME-CONTINUING>                            7066000
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   7066000
<EPS-PRIMARY>                                      .32
<EPS-DILUTED>                                      .32